FORWARD PURCHASE AGREEMENTForward Purchase Agreement • April 9th, 2021 • CM Life Sciences III Inc. • Blank checks • New York
Contract Type FiledApril 9th, 2021 Company Industry JurisdictionThis Forward Purchase Agreement (this “Agreement”) is entered into as of April 6, 2021, by and between CM Life Sciences III Inc., a Delaware corporation (the “Company”), and Corvex Management LP, a Delaware limited partnership, acting solely in its capacity as investment advisor (in such capacity, the “Advisor”) to one or more investment funds, clients or accounts (collectively, “Clients”) managed from time to time by the Advisor.
FORWARD PURCHASE AGREEMENTForward Purchase Agreement • April 9th, 2021 • CM Life Sciences III Inc. • Blank checks • New York
Contract Type FiledApril 9th, 2021 Company Industry JurisdictionThis Forward Purchase Agreement (this “Agreement”) is entered into as of April 6, 2021, by and between CM Life Sciences III Inc., a Delaware corporation (the “Company”), and Casdin Capital, LLC, a Delaware limited liability company, acting solely in its capacity as investment advisor (in such capacity, the “Advisor”) to one or more investment funds, clients or accounts (collectively, “Clients”) managed from time to time by the Advisor.
FORWARD PURCHASE AGREEMENTForward Purchase Agreement • February 26th, 2021 • CM Life Sciences II Inc. • Blank checks • New York
Contract Type FiledFebruary 26th, 2021 Company Industry JurisdictionThis Forward Purchase Agreement (this “Agreement”) is entered into as of February 22, 2021, by and between CM Life Sciences II Inc., a Delaware corporation (the “Company”), and Casdin Capital, LLC, a Delaware limited liability company, acting solely in its capacity as investment advisor (in such capacity, the “Advisor”) to one or more investment funds, clients or accounts (collectively, “Clients”) managed from time to time by the Advisor.
FORWARD PURCHASE AGREEMENTForward Purchase Agreement • February 26th, 2021 • CM Life Sciences II Inc. • Blank checks • New York
Contract Type FiledFebruary 26th, 2021 Company Industry JurisdictionThis Forward Purchase Agreement (this “Agreement”) is entered into as of February 22, 2021, by and between CM Life Sciences II Inc., a Delaware corporation (the “Company”), and Corvex Management LP, a Delaware limited partnership, acting solely in its capacity as investment advisor (in such capacity, the “Advisor”) to one or more investment funds, clients or accounts (collectively, “Clients”) managed from time to time by the Advisor.
FORWARD PURCHASE AGREEMENTForward Purchase Agreement • February 25th, 2021 • CM Life Sciences III Inc. • New York
Contract Type FiledFebruary 25th, 2021 Company JurisdictionThis Forward Purchase Agreement (this “Agreement”) is entered into as of , 2021, by and between CM Life Sciences III Inc., a Delaware corporation (the “Company”), and , a , acting solely in its capacity as investment advisor (in such capacity, the “Advisor”) to one or more investment funds, clients or accounts (collectively, “Clients”) managed from time to time by the Advisor.
FORWARD PURCHASE AGREEMENTForward Purchase Agreement • February 12th, 2021 • CM Life Sciences II Inc. • Blank checks • New York
Contract Type FiledFebruary 12th, 2021 Company Industry JurisdictionThis Forward Purchase Agreement (this “Agreement”) is entered into as of , 2021, by and between CM Life Sciences II Inc., a Delaware corporation (the “Company”), and , a , acting solely in its capacity as investment advisor (in such capacity, the “Advisor”) to one or more investment funds, clients or accounts (collectively, “Clients”) managed from time to time by the Advisor.
FORWARD PURCHASE AGREEMENTForward Purchase Agreement • September 4th, 2020 • CM Life Sciences, Inc. • Blank checks • New York
Contract Type FiledSeptember 4th, 2020 Company Industry JurisdictionThis Forward Purchase Agreement (this “Agreement”) is entered into as of September 1, 2020, by and between CM Life Sciences, Inc., a Delaware corporation (the “Company”), and Corvex Management LP, a Delaware limited partnership, acting solely in its capacity as investment advisor (in such capacity, the “Advisor”) to one or more investment funds, clients or accounts (collectively, “Clients”) managed from time to time by the Advisor.
FORWARD PURCHASE AGREEMENTForward Purchase Agreement • September 4th, 2020 • CM Life Sciences, Inc. • Blank checks • New York
Contract Type FiledSeptember 4th, 2020 Company Industry JurisdictionThis Forward Purchase Agreement (this “Agreement”) is entered into as of September 1, 2020, by and between CM Life Sciences, Inc., a Delaware corporation (the “Company”), and Casdin Capital, LLC, a Delaware limited liability company, acting solely in its capacity as investment advisor (in such capacity, the “Advisor”) to one or more investment funds, clients or accounts (collectively, “Clients”) managed from time to time by the Advisor.
FORWARD PURCHASE AGREEMENTForward Purchase Agreement • August 24th, 2020 • CM Life Sciences, Inc. • Blank checks • New York
Contract Type FiledAugust 24th, 2020 Company Industry JurisdictionThis Forward Purchase Agreement (this “Agreement”) is entered into as of [●], 2020, by and between CM Life Sciences, Inc., a Delaware corporation (the “Company”), and [●], a [●], acting solely in its capacity as investment advisor (in such capacity, the “Advisor”) to one or more investment funds, clients or accounts (collectively, “Clients”) managed from time to time by the Advisor.